BiotechTube

Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol

ApprovedCompleted
1 views this week 0 watching⚡ Active
Interest: 43/100
43
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Anesthesia

Conditions

Anesthesia

Trial Timeline

Nov 1, 2010 → Mar 1, 2011

NCT ID
NCT01260142

About Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol

Fospropofol disodium, propofol + Fospropofol disodium, propofol + Fospropofol disodium, propofol is a approved stage product being developed by Eisai for Anesthesia. The current trial status is completed. This product is registered under clinical trial identifier NCT01260142. Target conditions include Anesthesia.

What happened to similar drugs?

0 of 20 similar drugs in Anesthesia were approved

Approved (0) Terminated (0) Active (20)
🔄Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
🔄Ropivacaine + BupivacaineAstraZenecaPhase 3
🔄Sugammadex + neostigmineMerckPhase 3
🔄Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
🔄Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
🔄Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
🔄Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01260142ApprovedCompleted

Competing Products

20 competing products in Anesthesia

See all competitors
ProductCompanyStageHype Score
arm 1 + LUSEDRA + Propofol (arm 3)EisaiPhase 1
29
Remimazolam Tosilate for InjectionJiangsu Hengrui MedicinePre-clinical
26
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 3
40
Remimazolam TosylateJiangsu Hengrui MedicinePhase 1
29
HR020602 injection + fentanyl injection ； remifentanil injectionJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + PropofolJiangsu Hengrui MedicinePhase 2
35
Remimazolam Tosilate + Propofol Injection.Jiangsu Hengrui MedicinePhase 2
35
Ropivacaine + BupivacaineAstraZenecaPhase 3
40
SugammadexMerckPhase 2
35
SugammadexMerckPhase 2
35
Sugammadex + neostigmineMerckPhase 3
40
Sugammadex + Rocuronium + Sevoflurane + PropofolMerckPhase 3
40
Rocuronium + Sugammadex + Neostigmine + AtropineMerckPhase 3
40
Rocuronium 0.6 mg/kg intubating dose + Rocuronium 0.9 mg/kg intubating dose + Rocuronium 0.1 mg/kg maintenance dose + Rocuronium 0.15 mg/kg maintenance dose + Rocuronium 0.2 mg/kg maintenance + Vecuronium 0.1 mg/kg intubating dose + Vecuronium 0.025 mg/kg maintenance doseMerckPhase 3
40
Rocuronium bolus maintenance + rocuronium continuous infusion maintenanceMerckPhase 3
40
Sugammadex + RocuroniumMerckPhase 3
40
Sugammadex + NeostigmineMerckPhase 3
40
sugammadexMerckPhase 3
40
Sugammadex + Succinylcholine + RocuroniumMerckPhase 3
40
Rocuronium bromide + Rocuronium bromide + Rocuronium bromide + Sevoflurane + PropofolMerckPhase 3
40